Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20200119 | 0.75 | — | — | |
| SCHEMBL8345081 | 0.75 | — | — | |
| SCHEMBL8297519 | 0.73 | KMT2A (0.34) | KMT2AMEN1PABPC1 | |
| SCHEMBL8297578 | 0.71 | — | — | |
| SCHEMBL13765367 | 0.71 | — | — | |
| SCHEMBL17034250 | 0.71 | — | — | |
| SCHEMBL17472048 | 0.71 | L3MBTL1 (0.32) | — | |
| SCHEMBL8902606 | 0.69 | KMT2A (0.57) | KMT2AMEN1PABPC1ADRA2C | |
| SCHEMBL22269021 | 0.68 | KMT2A (0.34) | KMT2AMEN1PABPC1 | |
| SCHEMBL8297563 | 0.68 | KMT2A (0.39) | KMT2AMEN1PABPC1ADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174476-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD. (CN) | 2023-06-08 | — | — | US | disclosed |
| US-20090252685-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS | PREMIER RESEARCH INTERNATIONAL, LLC | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174476-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS | HPGDS, PTGER1, PTGIS | KMT2A 4430/4885MEN1 3170/4885PABPC1 2694/4885 |
| US-20090252685-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS | PTGER1, HPGDS, PTGER2 | KMT2A 4470/4885MEN1 3324/4885PABPC1 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.